Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
about
Heparin-induced thrombocytopenia: an updateLepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3Treatment of heparin-induced thrombocytopenia.Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies.Heparin-induced thrombocytopenia: natural history, diagnosis, and management.Comparison between different laboratory tests for the detection and prevention of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: pathophysiology and management.Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia with associated thrombosis in children after the Fontan operation: report of two casesHeparin-induced thrombocytopenia: pathogenesis and management.Heparin-induced thrombocytopenia in children.Pharmacotherapy of heparin- induced thrombocytopenia.Argatroban dosing in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia--recognition and treatment.Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.Acute myocardial infarction caused by delayed heparin-induced thrombocytopenia and acute immunoreaction due to re-exposure to heparin in a systemic lupus erythematosus patient with HIT antibodies.Unfractionated heparin: focus on a high-alert drug.Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparin.Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.New developments in diagnosis and treatment of heparin-induced thrombocytopenia.Fondaparinux: a potential new therapy for HIT.Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report.Argatroban in extracorporeal membrane oxygenation.Fondaparinux as a treatment option for heparin-induced thrombocytopenia.Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case seriesSafety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushesCurrent concepts review: heparin-induced thrombocytopenia.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.Weight-based argatroban dosing nomogram for treatment of heparin-induced thrombocytopenia.Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia.Lepirudin in the management of patients with heparin-induced thrombocytopenia.Profiling of heparin-induced thrombocytopenia antibody levels in patients with and without diabetes.Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
P2860
Q24815767-77B2730E-8A0E-477E-A490-91EE8920F856Q28278419-63CB94E2-D36D-4BD2-AD21-CDFF7D84963DQ31042575-77B398E7-ABEB-4356-A1BC-75FEA565785AQ33331831-8A26643D-FD8D-4D5E-BD28-2CCD910EB396Q33338785-7A247564-57B8-40F6-863C-A255B86EE1B4Q33340202-E50B0694-39DF-4BA5-A552-73C7854BB450Q33342924-672B0340-5654-47D2-B915-1FE5EA2D954FQ33343866-85FFD988-6496-4D95-B198-477E3BC8BDC5Q33344475-77E21090-1D24-4011-9F25-C8F6E3A3BAF9Q33346970-56ACAB07-CA95-48EA-BDE7-2D25732BA1C7Q33348049-94F380AD-6612-4551-B10C-D9B9DE405F67Q33348076-AFED79CC-EDAD-4247-900D-EDEC0444FF4DQ33348283-E725DBAE-EACD-48C2-B91C-2C759C4936A4Q33348817-689243C6-FCD9-40AE-A37B-1AF3D32FF2A9Q33349198-0977737D-BC57-4AE0-BBA5-5648124D45C1Q33349237-4DB9721F-48D0-4114-B734-E3A65B1C1EF4Q33357908-93CAC111-9BB7-4A7E-B990-88A16F958269Q33362322-0FA49E87-76E3-425A-A687-BC3F7A2A410AQ33363358-9D1A4AEB-F032-43E3-A23C-D9DB9C5C846CQ33364229-501818F5-A384-40E3-A719-B07F887452ADQ33364828-3F98B7C7-A08E-4011-88AC-A54B3FC44C73Q33367708-671BC130-488B-472E-9DDD-91CE07F2948AQ33369330-26876502-A573-46EC-8BD5-86FD25F78F81Q33370566-082C7FA2-A81F-476C-93D9-9FE45DAD23F6Q33370636-EAE81500-EFED-4432-A947-1450C3BAF5C6Q33373392-1E6050C9-4E9B-48D7-ADCA-8A36418F4BA4Q33374658-84024971-7673-4739-B60E-2B41DCF17608Q33375082-8FE6F97D-1928-41B2-957D-126D8C317DBAQ33375421-C36C3941-73E0-4184-B6EE-F93D074D0C1BQ33375448-2DCB3B91-79D9-4D13-BC30-DD42A04B02CBQ33380179-49706940-EC0B-4AB9-AF75-86F26BEC5140Q33380931-C60F5156-0245-409A-95F0-B60F3B22F2C7Q33381352-C814A653-1499-48EB-801C-ECC2F3A11B45Q33382108-B7FC8E8D-BE38-424C-8A64-2DEA2E0288CDQ33382275-2889C87F-C828-4B72-8414-A3946BD64644Q33382677-2DA769B9-84CA-4EEE-AFD0-3C3D2D16B2AAQ33385898-55DE3525-D927-4DD7-9E47-DFE5FC8C4117Q33385972-D0BB6976-12F5-4171-8A0A-AA4308D38731Q33388783-D7C2C9F4-EEFA-4A87-8818-7D8AA09F54AEQ33392854-3C1ABFE5-C268-4D15-AF33-DE67F0794975
P2860
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@ast
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@en
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@nl
type
label
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@ast
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@en
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@nl
prefLabel
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@ast
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@en
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@nl
P2093
P1476
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia.
@en
P2093
P304
P356
10.1016/S0002-9343(99)00124-2
P407
P577
1999-06-01T00:00:00Z